Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Multiple comparisons between the study groups

From: Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis

ItemsComparison pairs
 HC to SLEHC to LNAHC to LNISLE to LNASLE to LNILNA to LNI
Ureaz3.117− 7.605− 2.612− 11.12− 5.2934.051
P0.0110.0000.0540.0000.0000.000
Creatz13.3781.6106.66− 9.887− 3.2994.799
P0.0000.6450.0000.0000.0060.000
Urea/CreatLSD-t− 6.412− 8.119− 7.346− 3.381− 2.9320.104
P0.0000.0000.0000.0010.0030.917
CysCz− 13.005− 22.801− 13.561− 13.857− 4.4936.838
P0.0000.0000.0000.0000.0000.000
e-GFRCysCLSD-t14.34028.62415.29219.1285.322− 10.189
P0.0000.0000.0000.0000.0000.000
eGFRCreatLSD-t− 8.9333.053− 3.62911.1633.093− 5.959
P0.0000.0020.0000.0000.0020.000
C1qLSD-t6.02411.7894.2837.775− 0.091− 6.063
P0.0000.0000.0000.0000.9280.000
  1. ANOVA analysis or Kruskal-Wallis test was used for comparing the differences among the multiple groups. z/LSD-t and P were the statistical results for the comparison between the two groups. LSD-t was the statistics of ANOVA analysis to find the difference between the observed indicators of the normal distribution, and z was the statistics of Kruskal-Wallis non-parametric test to find the difference between the two observed indicators of the non-normal distribution
  2. Urea urea, Creat creatinine, CysC, cystatin C, C1q complement component 1q